LONDON, May 17 (Reuters) – AstraZeneca’s drive to
rebuild its portfolio of new medicines received a boost with
positive results for an experimental biotech drug for severe
asthma that the company…
The post UPDATE 1-AstraZeneca asthma drug hits goal, to enter competitive market appeared first on NASDAQ.